A detailed history of Geode Capital Management, LLC transactions in Essa Pharma Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 26,858 shares of EPIX stock, worth $46,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,858
Previous 26,858 -0.0%
Holding current value
$46,195
Previous $141,000 14.89%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$2.74 - $7.35 $21,424 - $57,469
7,819 Added 41.07%
26,858 $177,000
Q4 2021

Feb 11, 2022

BUY
$7.8 - $14.38 $24,593 - $45,340
3,153 Added 19.85%
19,039 $270,000
Q3 2021

Nov 12, 2021

SELL
$7.76 - $29.37 $66,650 - $252,258
-8,589 Reduced 35.09%
15,886 $127,000
Q2 2021

Aug 13, 2021

BUY
$24.17 - $34.28 $146,953 - $208,422
6,080 Added 33.05%
24,475 $699,000
Q1 2021

May 12, 2021

BUY
$11.61 - $32.08 $213,565 - $590,111
18,395 New
18,395 $534,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $75.8M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.